All Stories

  1. Suspected Perinatal Depression Revealed to be Hereditary Diffuse Leukoencephalopathy with Spheroids
  2. The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction
  3. Increased immune reactivity to central nervous system–derived naturally presented peptides in patients with active multiple sclerosis
  4. Influence of Formal Education on Cognitive Reserve in Patients with Multiple Sclerosis
  5. Benefit of ELISpot in early diagnosis of tuberculous meningoencephalitis: Case report and literature review
  6. Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases
  7. Oligoclonal bands predict multiple sclerosis in children with optic neuritis
  8. Immunvermittelte Erkrankungen des Nervensystems
  9. Autoimmune Enzephalitiden
  10. Activation of encephalitogenic T cells in a MOG-induced marmoset EAE model is regulated by linked suppression
  11. Treatment with atacicept enhances neuronal cell death in a rat model of optic neuritis
  12. Actively Induced Experimental Autoimmune Encephalomyelitis in Rats
  13. Peripheral Blood Mononuclear Cells: Isolation, Freezing, Thawing, and Culture
  14. The Immune Pathogenesis of Multiple Sclerosis
  15. Was ist die Ursache für Amnesie, Desorientiertheit und Epilepsie?
  16. Exogenous Schwann Cells Migrate, Remyelinate and Promote Clinical Recovery in Experimental Auto-Immune Encephalomyelitis
  17. Re-expression of N-cadherin in remyelinating lesions of experimental inflammatory demyelination
  18. Autoantigen Conformation Influences Both B- and T-cell Responses and Encephalitogenicity
  19. Experimental Autoimmune Encephalomyelitis - Models, Disease Biology and Experimental Therapy
  20. Experimental Autoimmune Encephalomyelitis
  21. Statins: a revised appraisal for potential additional future treatment indications
  22. Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity
  23. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis
  24. EAE: imperfect but useful models of multiple sclerosis
  25. Anti-MOG autoantibodies in children with acute demyelination: Comparison of assays and longitudinal analysis
  26. Progressive multifocal leukoencephalopathy
  27. Therapeutic Efficacy of Intranasally Delivered Mesenchymal Stem Cells in a Rat Model of Parkinson Disease
  28. Neurodegeneration in MS and NMO: The Eye and the Blood
  29. Cladribine
  30. Differential response to treatment of relapsing–remitting multiple sclerosis with IFN-β: is there a dichotomy into T-helper-1 and -17 driven disease?
  31. Neurofilament ELISA validation
  32. Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis
  33. PO10-TU-40 Mode of action (MoA) of cladribine tablets: activity in lymphocytes and implications for treatment of multiple sclerosis (MS)
  34. The autoimmunity-related polymorphism PTPN22 1858C/T is associated with anti-titin antibody-positive myasthenia gravis
  35. Naturally Presented Peptides on Major Histocompatibility Complex I and II Molecules Eluted from Central Nervous System of Multiple Sclerosis Patients
  36. Advanced Intercross Line Mapping Suggests That Ncf1 (Ean6) Regulates Severity in an Animal Model of Guillain-Barre Syndrome
  37. NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity
  38. Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes
  39. Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation
  40. Myelin-Reactive Type B T Cells and T Cells Specific for Low-Affinity MHC-Binding Myelin Peptides Escape Tolerance in HLA-DR Transgenic Mice
  41. The Use of Clinically Approved Small Particles of Iron Oxide (SPIO) for Labeling of Mesenchymal Stem Cells Aggravates Clinical Symptoms in Experimental Autoimmune Encephalomyelitis and Influences Their In Vivo Distribution
  42. Characterization of the encephalitogenic immune response in a model of multiple sclerosis
  43. Su.13. NCF1 Gene and Pseudogene Pattern: Association with Parasitic Infection and Autoimmunity
  44. Identification of HLA-DR–bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis
  45. Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland
  46. FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis
  47. I B Kinase 2/  Deficiency Controls Expansion of Autoreactive T Cells and Suppresses Experimental Autoimmune Encephalomyelitis
  48. Treatment of active secondary progressive multiple sclerosis with treosulfan
  49. Enhanced Glucocorticoid Receptor Signaling in T Cells Impacts Thymocyte Apoptosis and Adaptive Immune Responses
  50. Cortical Demyelination Can Be Modeled in Specific Rat Models of Autoimmune Encephalomyelitis and Is Major Histocompatability Complex (MHC) Haplotype-Related
  51. Notch1 and its ligand Jagged1 are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination
  52. The curtain is drawn for both natalizumab and fingolimod (FTY720): a new era of multiple sclerosis therapy has arrived
  53. MHC Gene Related Effects on Microglia and Macrophages in Experimental Autoimmune Encephalomyelitis Determine the Extent of Axonal Injury
  54. Ciliary Neurotrophic Factor Protects Retinal Ganglion Cells from Secondary Cell Death During Acute Autoimmune Optic Neuritis in Rats
  55. Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice
  56. IL4 mediated suppression of autoimmunity in the central nervous system
  57. Differential Processing of Autoantigens in Lysosomes from Human Monocyte-Derived and Peripheral Blood Dendritic Cells
  58. Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis
  59. CDR3 sequence preference of TCRBV8S2+ T cells within the CNS does not reflect single amino acid dependent avidity expansion
  60. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule
  61. Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis
  62. Diffusion Abnormality in Balo’s Concentric Sclerosis: Clues for the Pathogenesis
  63. Experimental Autoimmune Encephalomyelitis (EAE): Lesion Visualization on a 3 Tesla Clinical Whole-body System after Intraperitoneal Contrast Injection
  64. Hyperphosphorylation and Aggregation of Tau in Experimental Autoimmune Encephalomyelitis
  65. MHC and non-MHC gene regulation of disease susceptibility and disease course in experimental inflammatory peripheral neuropathy
  66. MHC Class II Isotype- and Allele-Specific Attenuation of Experimental Autoimmune Encephalomyelitis
  67. Lack of pathogenicity of immunodominant T and B cell determinants of the nicotinic acetylcholine receptor ε-chain
  68. Mechanisms and Time Course of Neuronal Degeneration in Experimental Autoimmune Encephalomyelitis
  69. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis
  70. Immunogenicity of Torpedo acetylcholine receptor in the context of different rat MHC class II haplotypes and non-MHC genomes
  71. Analysis of Autoreactive CD4 T Cells in Experimental Autoimmune Encephalomyelitis after Primary and Secondary Challenge Using MHC Class II Tetramers
  72. Qualitative und nicht quantitative Eigenschaften autoreaktiver T-Helfer-Lymphozyten bestimmen die Ausprägung einer ZNS-gerichteten Autoimmunerkrankung
  73. Modulation of neuronal activity by the endogenous pentapeptide QYNAD
  74. Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes
  75. CD8+ Phagocyte Recruitment in Rat Experimental Autoimmune Encephalomyelitis
  76. Suppressive DNA Vaccination in Myelin Oligodendrocyte Glycoprotein Peptide-Induced Experimental Autoimmune Encephalomyelitis Involves a T1-Biased Immune Response
  77. High Immunogenicity of Intracellular Myelin Oligodendrocyte Glycoprotein Epitopes
  78. T Cell Epitopes of Human Myelin Oligodendrocyte Glycoprotein Identified in HLA-DR4 (DRB1*0401) Transgenic Mice Are Encephalitogenic and Are Presented by Human B Cells
  79. Immunoglobulin isotypes reveal a predominant role of type 1 immunity in multiple sclerosis
  80. Polygenic control of autoimmune peripheral nerve inflammation in rat
  81. Congenic mapping confirms a locus on rat chromosome 10 conferring strong protection against myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis
  82. MHC Class II-Regulated Central Nervous System Autoaggression and T Cell Responses in Peripheral Lymphoid Tissues Are Dissociated in Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis
  83. Intra-CNS activation by antigen-specific T lymphocytes in experimental autoimmune encephalomyelitis
  84. Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis
  85. Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
  86. Genetics of rat neuroinflammation
  87. Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen
  88. Linkage Analysis of Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis in the Rat Identifies a Locus Controlling Demyelination on Chromosome 18
  89. Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology
  90. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis
  91. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis
  92. MHC haplotype-dependent regulation of MOG-induced EAE in rats.
  93. Analysis of acetylcholine receptor (AChR)-specific T cell receptors (TCRs)
  94. Microglia versus macrophages in the pathogenesis of chronic myelin oligodendroglia glycoprotein (MOG)EAE lesions
  95. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis
  96. Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of IgG suppresses experimental autoimmune encephalomyelitis
  97. MHC haplotype-dependent regulation of the clinical profile & lesional pathology of myelin-oligodendrocyte-glycoprotein induced experimental autoimmune encephalomyelitis
  98. Binding stretches of myelin basic protein define encephalitogenic T cell epitopes for RT1.B and RT1.D alleles of four different rat haplotypes
  99. Vaccination with DNA Encoding an Immunodominant Myelin Basic Protein Peptide Targeted to Fc of Immunoglobulin G Suppresses Experimental Autoimmune Encephalomyelitis
  100. Late-Onset Myasthenia Gravis: Follow-up of 113 Patients Diagnosed after Age 60
  101. Genetic analysis of inflammation, cytokine mRNA expression and disease course of relapsing experimental autoimmune encephalomyelitis in DA rats
  102. Altered tumor growth factor β mRNA expression is associated with thymectomy-related clinical remission in myasthenia gravis
  103. Major histocompatibility complex haplotype RT1av1 is associated with relapsing/remitting experimental autoimmune encephalomyelitis
  104. T Cell Epitopes of the Acetylcholine Receptor and the Pathogenesis of Myasthenia Gravis
  105. Peptide sequences containing potential HLA B8-restricted T-cell epitopes of the acetylcholine receptor
  106. Allele-specific T cell epitopes on the acetylcholine receptor in myasthenia gravis patients
  107. Specific immune complexes augment in vitro acetykholine receptor-specific T-cell proliferation
  108. Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis.